Skip to main content
logo
Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
13.89
+0.09 (0.65%)
At close: Jul 29, 2025, 4:00 PM
13.92
+0.03 (0.22%)
After-hours: Jul 29, 2025, 7:58 PM EDT

RGC Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2020
Net Income
--4.3-5.87-7.45-1.35-0.81
Upgrade
Depreciation & Amortization
-0.750.770.60.030.01
Upgrade
Loss (Gain) From Sale of Assets
--0---
Upgrade
Stock-Based Compensation
-0.450.922.76--
Upgrade
Other Operating Activities
--0.31-0.28-0.16--
Upgrade
Change in Other Net Operating Assets
--0.59-0.51-1.020.550.08
Upgrade
Operating Cash Flow
--4-4.96-5.27-0.77-0.73
Upgrade
Capital Expenditures
--0.01-0.03-0.78--0.12
Upgrade
Sale of Property, Plant & Equipment
--0---
Upgrade
Investment in Securities
-5.250.09-10--
Upgrade
Investing Cash Flow
-5.240.06-10.78--0.12
Upgrade
Short-Term Debt Issued
----0.610.99
Upgrade
Total Debt Issued
----0.610.99
Upgrade
Short-Term Debt Repaid
----0.43--
Upgrade
Total Debt Repaid
----0.43--
Upgrade
Net Debt Issued (Repaid)
----0.430.610.99
Upgrade
Issuance of Common Stock
---22.67--
Upgrade
Other Financing Activities
-0.10.130.16-0.17-
Upgrade
Financing Cash Flow
-0.10.1322.410.440.99
Upgrade
Foreign Exchange Rate Adjustments
-0.05-0.08---
Upgrade
Net Cash Flow
-1.4-4.856.36-0.330.14
Upgrade
Free Cash Flow
--4.01-4.99-6.05-0.77-0.84
Upgrade
Free Cash Flow Per Share
--0.01-0.01-0.01-0.00-0.00
Upgrade
Levered Free Cash Flow
--1.88-2.28-2.69-0.28-0.52
Upgrade
Unlevered Free Cash Flow
--1.88-2.28-2.69-0.28-0.52
Upgrade
Change in Net Working Capital
-0.130.030.51-0.55-0.1
Upgrade
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q